Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (321-330 of 432) with videos related to

Pageof 44
Sort By:
Brain Communications|February 18, 2025
Association of plasma soluble urokinase plasminogen activator receptor concentrations and migraine with aura: a REFORM studyBetel Tesfay, Håkan Ashina, Rune Häckert Christensen, et al.
Human Brain Mapping|September 17, 2013
Interhemispheric differences of fMRI responses to visual stimuli in patients with side-fixed migraine auraAnders Hougaard, Faisal Mohammad Amin, Michael B Hoffmann, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialHong Sun, David W Dodick, Stephen Silberstein, et al.
Headache|September 20, 2019
Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral ArteriesMohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Jakob M Hansen, et al.
Peptides|December 4, 2018
High doses of ANP and BNP exacerbate lipolysis in humans and the lipolytic effect of BNP is associated with cardiac triglyceride content in pigsEmil D Bartels, Song Guo, Birgitte S Kousholt, et al.
Cephalalgia : an International Journal of Headache|July 10, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyMessoud Ashina, Stewart Tepper, Jan Lewis Brandes, et al.
Pain|July 24, 2020
Intradural artery dilation during experimentally induced migraine attacksCasper E Christensen, Samaira Younis, Ulrich Lindberg, et al.
Headache|June 18, 2020
S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?Agneta H Snoer, Anne Luise H Vollesen, Rasmus Paulin Beske, et al.
Cephalalgia : an International Journal of Headache|February 5, 2021
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION studyMessoud Ashina, Uwe Reuter, Timothy Smith, et al.
Pageof 44

Showing results (321-330 of 432) with videos related to

Sort By:
Pageof 44
Brain Communications|February 18, 2025
Association of plasma soluble urokinase plasminogen activator receptor concentrations and migraine with aura: a REFORM studyBetel Tesfay, Håkan Ashina, Rune Häckert Christensen, et al.
Human Brain Mapping|September 17, 2013
Interhemispheric differences of fMRI responses to visual stimuli in patients with side-fixed migraine auraAnders Hougaard, Faisal Mohammad Amin, Michael B Hoffmann, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialHong Sun, David W Dodick, Stephen Silberstein, et al.
Headache|September 20, 2019
Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral ArteriesMohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Jakob M Hansen, et al.
Peptides|December 4, 2018
High doses of ANP and BNP exacerbate lipolysis in humans and the lipolytic effect of BNP is associated with cardiac triglyceride content in pigsEmil D Bartels, Song Guo, Birgitte S Kousholt, et al.
Cephalalgia : an International Journal of Headache|July 10, 2018
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyMessoud Ashina, Stewart Tepper, Jan Lewis Brandes, et al.
Pain|July 24, 2020
Intradural artery dilation during experimentally induced migraine attacksCasper E Christensen, Samaira Younis, Ulrich Lindberg, et al.
Headache|June 18, 2020
S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?Agneta H Snoer, Anne Luise H Vollesen, Rasmus Paulin Beske, et al.
Cephalalgia : an International Journal of Headache|February 5, 2021
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION studyMessoud Ashina, Uwe Reuter, Timothy Smith, et al.
Pageof 44